Hedge Fund - Vestal Point Capital
Ultragenyx Pharmaceutical Inc. (RARE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $32.89 |
| 2 | 2025 - Q3 (2025-09-30) | $22,560,000 | 1.02% | 750,000 | $29.99 |
| 3 | 2025 - Q2 (2025-06-30) | $0 | 0% | 0 | $36.05 |
| 4 | 2025 - Q1 (2025-03-31) | $18,105,000 | 1.29% | 500,000 | $41.60 |
| 5 | 2024 - Q4 (2024-12-31) | $63,105,000 | 3.74% | 1,500,000 | $49.61 |
| 6 | 2024 - Q3 (2024-09-30) | $41,662,500 | 3.15% | 750,000 | $50.94 |
| 7 | 2024 - Q2 (2024-06-30) | $73,980,000 | 5.51% | 1,800,000 | $42.70 |
| 8 | 2024 - Q1 (2024-03-31) | $5,135,900 | 0.42% | 110,000 | $47.17 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center